Apogee Therapeutics, Inc. (NASDAQ:APGE) showed up in the 13F filings of 203 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VR Adviser, LLC | 31 Dec, 2025 | 8,493,321 | 0 | 0.00% | $641,075,869.00 |
| FMR LLC | 31 Dec, 2025 | 8,225,038 | 1,308,576 | 18.92% | $620,825,834.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 4,746,585 | 22,884 | 0.48% | $358,272,236.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 4,288,443 | 4,287,002 | 297,501.88% | $323,692.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,783,994 | 1,097,968 | 40.88% | $285,615,865.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,857,824 | 612,193 | 27.26% | $215,708,556.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 2,712,097 | 0 | 0.00% | $204,709,082.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 2,330,651 | 978,662 | 72.39% | $175,917,537.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 2,183,704 | 25,202 | 1.17% | $164,825,978.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 2,062,604 | 1,576,626 | 324.42% | $155,697,275.00 |
| Fairmount Funds Management LLC | 31 Dec, 2025 | 2,048,647 | 0 | 0.00% | $154,631,876.00 |
| State Street Corp | 31 Dec, 2025 | 1,690,186 | 34,638 | 2.09% | $127,575,239.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 1,373,066 | -902,396 | -39.66% | $103,639,021.00 |
| Affinity Asset Advisors, LLC | 31 Dec, 2025 | 1,234,926 | 61,500 | 5.24% | $93,212,214.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 1,130,820 | 531,204 | 88.59% | $85,354,294.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 1,123,243 | -398,514 | -26.19% | $84,782,382.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Dec, 2025 | 1,093,657 | -325,475 | -22.93% | $82,549,230.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,059,085 | 166,882 | 18.70% | $79,957,396.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 1,000,000 | 1,000,000 | 0.00% | $75,480,000.00 |
| UBS Group AG | 31 Dec, 2025 | 974,826 | 175,361 | 21.93% | $73,579,866.00 |